<?xml version="1.0" encoding="UTF-8"?>
<results title="country">
 <result pre="Syndrome Coronavirus 2 (SARS-CoV-2) ChoudhryNamrtaâ€ #ZhaoXinâ€¡#XuDanâ€ ZaninMarkÂ§âŠ¥ChenWeisan*âˆ¥YangZifeng*Â§ChenJianxin*â€ [â€ ], South" exact="China" post="Agricultural UniversityChina[â€¡], Guangdong Institute of Analysis (China National Analytical"/>
 <result pre="East respiratory syndrome (MERS), caused by MERS-CoV, emerged in the" exact="Kingdom of Saudi Arabia" post="and subsequently spread to 27 countries.7 MERS presented as"/>
 <result pre="syndrome (MERS), caused by MERS-CoV, emerged in the Kingdom of" exact="Saudi Arabia" post="and subsequently spread to 27 countries.7 MERS presented as"/>
 <result pre="COVID-19. In 2002â€&quot;2003, the SARS outbreak first started in South" exact="China" post="and subsequently spread to 31 countries worldwide. Patients in"/>
 <result pre="and subsequently spread to 31 countries worldwide. Patients in mainland" exact="China" post="accounted for over 60% of the total cases. Interestingly,"/>
 <result pre="the total cases. Interestingly, the average death rate in mainland" exact="China" post="(approximately 6.5%) was lower than the worldwide average death"/>
 <result pre="worldwide average death rate (9.3%). The higher cure rate in" exact="China" post="for SARS infections was attributed to combining traditional Chinese"/>
 <result pre="On January 20, 2020, the National Health Commission (NHC) of" exact="China" post="issued the first edition of the Guidelines for the"/>
 <result pre="to 15 clinical trials of CQ or hydroxychloroquine (HCQ) in" exact="China" post="to test their efficacy and safety for COVID-19 patients."/>
 <result pre="Western medicine.24 A total of 92% of COVID-19 patients in" exact="China" post="received TCM treatment, with a total effective rate of"/>
 <result pre="patients from 12 hospitals in Guangdong and Hubei Provinces in" exact="China" post="were treated with CQ, and 176 patients were included"/>
 <result pre="a therapeutic evaluation of HCQ in 36 COVID-19 patients in" exact="France" post="and suggested that 600 mg/day HCQ significantly reduced viral"/>
 <result pre="(T-705, 3), a guanine analog approved for influenza treatment in" exact="Japan" post="in 2014, can effectively inhibit the RNA-dependent RNA polymerase"/>
 <result pre="medicines have been extensively used to treat COVID-19 patients in" exact="China" post="and have achieved positive effects. However, the major challenges"/>
 <result pre="with the Council of Scientific and Industrial Research- NBRI, Lucknow" exact="India" post="in 2015, later she joined a project entitled â€˜World"/>
 <result pre="IAV and CoVs at the College of Veterinary Medicine, South" exact="China" post="Agricultural University in Guangzhou, China. Xin Zhao received his"/>
 <result pre="has been working at the College of Veterinary Medicine, South" exact="China" post="Agriculture University, in Guangzhou, China. Her main research interests"/>
 <result pre="Guangzhou, and the School of Public Health, The University of" exact="Hong Kong." post="He earned a Ph.D. from Monash University, Australia, in"/>
 <result pre="discovered the 11th IAV gene product PB1-F2. He returned to" exact="Australia" post="in 2001 and established his independent T Cell Laboratory"/>
 <result pre="Chen is a professor at College of Veterinary Medicine, South" exact="China" post="Agricultural University in Guangzhou, China. He earned a B.S."/>
 <result pre="We also acknowledge Prof. Jing Zhao from the University of" exact="Macau" post="and Prof. Geng Li from Guangzhou University of Chinese"/>
 <result pre="funded by the National Key Research and Development Program of" exact="China" post="(Grant 2017YFD0501404), Guangdong Special Support Program Innovation Team (Grant"/>
 <result pre="cause of severe acute respiratory syndrome (SARS) in Guangdong, Peopleâ€™s" exact="Republic of" post="China, in February, 2003. Lancet2003, 362, 1353â€&quot;1358. 10.1016/S0140-6736(03)14630-2.14585636 KsiazekT."/>
 <result pre="UyekiT. M.; PillaiS. K.First case of 2019 novel coronavirus in" exact="the United States." post="N. Engl. J. Med.2020, 382, 929â€&quot;936. 10.1056/NEJMoa2001191.32004427 GreinJ.; OhmagariN.;"/>
 <result pre="M.; PillaiS. K.First case of 2019 novel coronavirus in the" exact="United States." post="N. Engl. J. Med.2020, 382, 929â€&quot;936. 10.1056/NEJMoa2001191.32004427 GreinJ.; OhmagariN.;"/>
 <result pre="severe acute respiratory syndrome human coronavirus. Proc. Natl. Acad. Sci." exact="U. S." post="A.2004, 101, 10012â€&quot;10017. 10.1073/pnas.0403596101.15226499 ChandwaniA.; ShuterJ.Lopinavir/ritonavir in the treatment"/>
 <result pre="structure of a viral deubiquitinating enzyme. Proc. Natl. Acad. Sci." exact="U. S." post="A.2006, 103, 5717â€&quot;5722. 10.1073/pnas.0510851103.16581910 DevarajS. G.; WangN.; ChenZ.; ChenZ.;"/>
 <result pre="S1 protein that blocks receptor association. Proc. Natl. Acad. Sci." exact="U. S." post="A.2004, 101, 2536â€&quot;2541. 10.1073/pnas.0307140101.14983044 YuanB.; YangR.; MaY.; ZhouS.; ZhangX.;"/>
 <result pre="and their derivatives are widely implicated in liver cancers in" exact="Taiwan" post="and throughout Asia. Sci. Transl. Med.2017, 9, eaan644610.1126/scitranslmed.aan6446.29046434 ZengZ."/>
</results>
